RightAnswer Knowledge Solutions provides access to hundreds of data sources. Our premier and proprietary sources include fully-researched documents from well-established experts in the chemical and HazMat fields.
A search in our system for this chemical would return results – all in one place -- in the following categories from the listed data sources.
- Chemical Identification
- Environmental Hazards
- First Aid/Medical Treatment
- Handling/Storage/Shipping/Waste Management
- Personal Protection
- Physical Hazards/Corrective Response Actions
- Physical/Chemical Properties
- Report Abstracts and Studies
- Reproductive Risk
- Toxicology/Health Hazards/Exposure
|Example of Acute Exposure data from MEDITEXT.|
RightAnswer Proprietary Data Sources:
Other Government Links Searched via RegsKnowledge:
State Environmental Regulations
Example Content from MEDITEXT for 29767-20-2:
Please note: this is an extract of information from a larger document. Full document and details are available by subscription.
ACUTE EXPOSURE INFORMATION
- WITH THERAPEUTIC USE
- Myelosuppression is the dose-limiting toxicity and a frequent occurrence with teniposide therapy. Other adverse effects that may commonly occur with teniposide therapy include nausea, vomiting, mucositis, and diarrhea. Hypersensitivity reactions, consisting of chills, fever, tachycardia, flushing, bronchospasm, dyspnea, and blood pressure changes (hypotension or hypertension), and transient hypotension following rapid intravenous administration have been infrequently reported in pediatric patients.
- WITH POISONING/EXPOSURE
- Teniposide overdose information is limited. Severe myelosuppression is the anticipated effect following overdose. Hypotension, metabolic acidosis and somnolence have been reported after 3 to 5 tomes the usual therapeutic dose.
© 2011-2020 RightAnswer.com, Inc. and/or its licensors. All rights reserved. No claim to original U.S. Govt. works.